Article Sidebar
Published:
Jan 13, 2022Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Development and validation of a novel chemiluminescent immunoassay for diagnosing primary aldosteronism
Abstract
Purpose: To compare the diagnostic accuracy of plasma aldosterone concentration (PAC), plasma renin activity (PRA) and aldosterone-to-renin ratio (ARR) in primary aldosteronism (PA) using radioimmunoassay (RIA) and chemiluminescence immunoassay (CLIA) methods.
Methods: Both RIA and CLIA were used to analyze the PAC, PRA and ARR with subjects in standing or supine position, before and after a saline infusion test (SIT). The correlation between RIA and CLIA was measured by regression analysis. The receiver operating characteristic (ROC) curve was used to evaluate the diagnostic accuracy by RIA and CLIA.
Results: A positive correlation was found between PAC and PRA after SIT using RIA and CLIA (0.1745 and 0.3085, respectively). A positive correlation was found between the PAC and PRA in standing and supine position using RIA and CLIA (0.3979 vs 0.2399 and 0.1885 vs 0.4032, respectively). There was no obvious difference in AUCs of PAC, PRA, and ARR between RIA and CLIA (PAC: 0.91 vs. 0.89; PRA: 0.88 vs. 0.87; ARR: 0.93 vs. 0.92). In standing posture, the AUCs of PAC, PRA and ARR using RIA were 0.63, 0.72 and 0.78, respectively, and the results of CLIA were 0.65, 0.75 and 0.82, respectively. In supine posture, the AUC of PAC, PRA and ARR using RIA was 0.65, 0.68 and 0.71, respectively, and the results of CLIA were 0.68, 0.70 and 0.79, respectively.
Conclusion: Chemiluminescent assay is reliable for diagnosis of PA when compared with radioimmunoassay.
